AzTrials
AzTrials

Burnout, ProfessionalPT-BURNOUT-TRNCT07722858

Factors Affecting Burnout in Physiotherapists in Turkey

An observational study of Burnout, Professional and Occupational Stress, run by Acibadem University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This cross-sectional descriptive study aims to identify the demographic, occupational, organisational and individual psychological factors that predict burnout among physiotherapists working in active clinical practice in Turkey. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
400 participants
Where
1 siteTurkey (Türkiye)
Study dates
Jul 2026to Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Licensed physiotherapists in active clinical practice in Turkey, working across a range of sectors and clinical fields. Participants are recruited nationwide by snowball and purposive sampling through the Turkish Physiotherapy Association, professional social media groups and university physiotherapy departments.

Who may be able to join

  • Licensed physiotherapist in Turkey
  • Currently working in active clinical practice
  • Provides electronic informed consent

Who cannot join

  • Not currently working in clinical practice
  • Incomplete questionnaire, defined as responding to less than 50 percent of the COPSOQ III items

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Acibadem Mehmet Ali Aydinlar University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    Istanbul, 34752

    Hasan Gercek, PhD, +90 542 648 8455, hasan.gercek@acibadem.edu.tr

    Hasan Gercek, PhD

Other trials in Turkey (Türkiye)

About this study

Official title: Examination of Factors Affecting Burnout in Physiotherapists in Turkey: A Hierarchical Regression Analysis

This cross-sectional descriptive study aims to identify the demographic, occupational, organisational and individual psychological factors that predict burnout among physiotherapists working in active clinical practice in Turkey. Using a four-block hierarchical multiple regression approach, the relative contribution of workload and role factors, organisational factors, psychological resilience, self-efficacy and Type A behaviour pattern to the three dimensions of burnout (emotional exhaustion, depersonalisation and personal accomplishment) will be quantified. Turnover intention is examined as a secondary dependent variable. Data are collected through an anonymous online survey distributed nationwide.

Keywords
Burnout, Physiotherapists, Physical therapy, Occupational health, Psychosocial work environment, Resilience, Self-efficacy, Type A behaviour pattern, Turnover intention, Hierarchical regression
Medical subject headings
Burnout, Professional, Occupational Stress, Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07722858
Study groupRoleWhat they receive
Physiotherapists in active clinical practice in TurkeyLicensed physiotherapists working in active clinical practice across Turkey, recruited nationwide through professional associations, professional social media groups and university physiotherapy departments. Participants complete a single anonymous online questionnaire battery; no intervention is applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Burnout (Maslach Burnout Inventory, MBI)

    The MBI is a 22-item self-report instrument assessing burnout in three subscales: emotional exhaustion (9 items), depersonalisation (5 items) and personal accomplishment (8 items). Items are rated on a five-category frequency scale from 0 (never) to 4 (always). The personal accomplishment subscale is reverse scored, so that lower scores on that subscale indicate greater burnout; higher scores on emotional exhaustion and depersonalisation indicate greater burnout. Each subscale is analysed as a separate dependent variable.

    Measured: Single assessment at enrollment (Day 1)

Secondary outcomes (5)
  1. Turnover intention (Mobley Turnover Intention Scale)

    A 3-item scale assessing intention to leave the current job across three dimensions: thinking of quitting, intention to search for alternative employment and probability of leaving. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree), giving a total score of 3 to 15. Higher scores indicate greater turnover intention. Used as a secondary dependent variable.

    Measured: Single assessment at enrollment (Day 1)

  2. Psychosocial work environment (Copenhagen Psychosocial Questionnaire III, COPSOQ III)

    COPSOQ III comprises 87 items across 25 subscales. Each subscale is scored separately on a 0 to 100 scale, with 0 to 33 indicating low risk, 33 to 66 moderate risk and 66 to 100 high risk. Job satisfaction items use a 4-point Likert format and the remaining dimensions a 5-point Likert format. High scores on quantitative demands, emotional demands and role conflict are interpreted as risk factors, whereas high scores on the remaining subscales are interpreted as protective factors. Workload, role and organisational subscales serve as predictor blocks in the regression models.

    Measured: Single assessment at enrollment (Day 1)

  3. Psychological resilience (Connor-Davidson Resilience Scale, CD-RISC-10)

    The 10-item short form of the Connor-Davidson Resilience Scale, assessing coping with adversity, adaptation to change, seeking social support and self-confidence over the past month. Items are rated from 0 (not true at all) to 4 (true nearly all the time), giving a total score of 0 to 40. Higher scores indicate greater resilience. There are no reverse-scored items.

    Measured: Single assessment at enrollment (Day 1)

  4. General self-efficacy (Self-Efficacy Scale)

    A 17-item scale assessing general perceived self-efficacy in coping with everyday difficulties, maintaining goal-directed behaviour and dealing effectively with novel situations. Items are rated on a 5-point Likert scale from 1 to 5, giving a total score of 17 to 85, with higher scores indicating greater perceived self-efficacy. Eleven items are reverse worded and are reverse coded before analysis.

    Measured: Single assessment at enrollment (Day 1)

  5. Type A behaviour pattern (Bortner Rating Scale, short form)

    A bipolar 7-item scale based on the Type A and Type B personality model. For each item a value between 1 and 8 is selected, with the left pole representing Type B (calm, less competitive) and the right pole Type A (hurried, highly competitive) characteristics. The raw total is multiplied by three to obtain the final score, ranging from 21 to 168; scores of 100 and above indicate Type A and scores below 100 indicate Type B characteristics.

    Measured: Single assessment at enrollment (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07722858
Sponsor's protocol ID
AcibademHG2
Acronym
PT-BURNOUT-TR
Status last verified
Jul 2026
First submitted
20 Jul 2026
Last updated
23 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Burnout, Professional and Occupational Stress, run by Acibadem University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hasan Gercek, PhD (+90 542 648 8455, hasan.gercek@acibadem.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Burnout (Maslach Burnout Inventory, MBI) (time frame: Single assessment at enrollment (Day 1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in